Your session is about to expire
← Back to Search
Psilocybin for Religious Leaders' Experiential Enhancement
Study Summary
This trial is testing whether psilocybin can help religious leaders have more meaningful experiences.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 95 Patients • NCT02061293Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I agree not to use psychoactive substances or smoke regularly around my treatment times.I agree to keep my caffeine intake the same on the days I have psilocybin sessions.I agree not to use psychoactive substances or smoke regularly around my treatment times.My weight is more than 20% over or under the ideal range for my height.I take prescribed mental health medication daily.I take prescribed mental health medication daily.I agree to keep my caffeine intake the same on the days I have psilocybin sessions.I haven't had major heart issues like a stroke or uncontrolled high blood pressure in the past year.I agree not to take any erectile dysfunction medication 72 hours before each treatment.I agree not to take any non-prescribed drugs or supplements before each drug session, except for approved exceptions.I agree not to take medications like Viagra within 72 hours of each treatment.I agree not to take any over-the-counter meds, supplements, or herbs before each drug session, except when allowed.You have had a problem with alcohol or drug abuse in the past 5 years or have had severe depression.I haven't had major heart issues or strokes in the past year.I agree not to take any non-prescribed drugs or supplements before drug sessions, except for approved exceptions.I agree not to take any 'as needed' medications on the mornings I receive treatment.I agree not to use psychoactive substances or smoke regularly around my treatment times.I have diabetes and use insulin without experiencing low blood sugar.I am healthy and mentally stable, confirmed by medical tests and interviews.I agree not to take any 'as needed' medications on the mornings I receive treatment.I agree not to take any erectile dysfunction medication 72 hours before each treatment.I agree to keep my caffeine intake the same on the days I have psilocybin sessions.There is no foreseeable likelihood for a major life-altering event for her or himself or a close family member during the next year.I have epilepsy with a history of seizures.I have epilepsy with a history of seizures.My weight is more than 20% over or under the ideal range for my height.I am not pregnant, nursing, or if capable of becoming pregnant, I am using effective birth control.I am not currently taking daily medications that affect serotonin or are MAO inhibitors.You have been diagnosed with schizophrenia or bipolar disorder, except if it was caused by drugs or a medical condition.I am healthy and mentally stable, confirmed by medical exams and tests.You are a leader in a well-known religious organization and spend a lot of time helping people seeking spiritual guidance or support.I have given my written permission.I am not pregnant, nursing, or if capable of becoming pregnant, I am using effective birth control.You hold a high position in a religious organization and spend a lot of time helping people seeking spiritual guidance or support.A close family member has Schizophrenia, Psychotic Disorder, or Bipolar I/II.I am not currently taking daily medications that affect serotonin or are MAO inhibitors.I am healthy and mentally stable, confirmed by medical tests and interviews.I have diabetes and use insulin without experiencing low blood sugar.I agree not to take any 'as needed' medications on the mornings I receive treatment.The applicant must have a college degree or equivalent, and be a graduate or professional.
- Group 1: Immediate Participation
- Group 2: Delayed Participation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Have any other experiments utilized Psilocybin in their research?
"Currently, there are 33 ongoing Psilocybin trials. 0 of these clinical studies have reached the Phase 3 stage yet. While a majority of them originate in Vancouver, Washington, they span across 36 different locations worldwide."
What criteria make someone a suitable candidate for this research?
"This clinical trial is open to healthy adults between the ages of 25 and 80. Up to 20 participants can be included in this medical study."
To what extent has participation in this medical experiment been extended?
"Sadly, this trial is no longer open to patients. It was initially listed on March 1st 2015 and the last update occurred May 31st 2022. However, there are currently 840 trials for healthy subjects (hs) that admit participants as well as 33 studies involving psilocybin actively recruiting patients."
Does this trial have an age restriction and, if so, is it open to persons above the age of 18?
"According to the trial's guidelines, applicants aged between 25 and 80 are eligible. Additionally, there are 50 spots reserved for participants younger than 18 years old and 401 vacancies available for individuals over 65."
Are there still opportunities to participate in this research protocol?
"At this moment, the study is not seeking out new participants. The research was initially launched on March 1st 2015 and most recently updated on May 31 2022. However, if you wish to look into other trials there are currently 840 studies recruiting healthy subjects (hs) as well 33 clinical experiments exploring psilocybin treatments actively searching for patients."
What safeguards are in place to ensure the safe use of Psilocybin?
"Taking into account the limited evidence related to Psilocybin's efficacy and safety, our team at Power assigned it a score of 1."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger